Author

P. C. DeMuth

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Jakubowski· 3 shared C. M. Haqq· 3 shared L. M. Seenappa· 3 shared M. P. Steinbuck· 3 shared L. K. McNeil· 2 shared A. M. Abbas· 1 shared C. Carter· 1 shared D. J. Drakes· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

A. Jakubowski

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintMay 19, 2022

Programming the lymph node immune response with Amphiphile-CpG induces potent cellular and humoral immunity following COVID-19 subunit vaccination in mice and non-human primates

L. M. Seenappa, A. Jakubowski, M. P. Steinbuck…·P. C. DeMuth

This study evaluates an AMP-CpG adjuvant in combination with SARS-CoV-2 RBD as a subunit vaccine, showing enhanced T cell and cross-reactive antibody responses in mice and NHPs.

DOI 10.1101/2022.05.19.492649

mousenon-human primate

𝕏 PostBluesky

ImmunologybioRxivPreprintMay 5, 2022

Lymph node-targeted vaccine boosting of TCR-T cell therapy enhances anti-tumor 1 function and eradicates solid tumors

D. J. Drakes, A. M. Abbas, J. Shields…·P. C. DeMuth

This paper shows that combining AMP-vaccination with TCR-T cell therapy improves T cell persistence and anti-tumor activity, leading to solid tumor eradication in mice.

DOI 10.1101/2022.05.05.490779

mouseCITE-seq

𝕏 PostBluesky

ImmunologybioRxivAug 17, 2020

A Lymph Node Targeted Amphiphile Vaccine Induces Potent Cellular and Humoral Immunity to SARS-CoV-2

M. P. Steinbuck, L. M. Seenappa, A. Jakubowski…·P. C. DeMuth

This study evaluates a novel amphiphile vaccine adjuvant, AMP-CpG, which induces strong cellular and humoral immunity against SARS-CoV-2 in mice.

DOI 10.1126/sciadv.abe5819

mouseprotein sequence

𝕏 PostBluesky